# Trade Mark Journal No.2025/043 24 October 2025

## WO0000001879992 (5)

Office of origin: United States of America

Date of International Registration:27 August 2025
Date of designation in the UK: 27 August 2025

International priority date claimed: 3 March 2025 (United States of America) (99064092)

Class 5
  Cells and biological preparations intended for medical and clinical use, namely, T cells which have undergone adaptations to combat diseases.

Nant Holdings IP, LLC

Representative: Michael J. McCue Womble Bond Dickinson (US) LLP, 3993 Howard Hughes Parkway, Suite 600, Las Vegas NV 89169, UNITED STATES OF AMERICA